Intramuscular Bioavailability

Intramuscular Bioavailability is the fraction and rate at which a drug administered intramuscularly reaches the systemic circulation in an unchanged form, distinguishing it from bioavailability via other routes by its dependence on local muscle perfusion, injection technique, and physicochemical properties of the formulation.

155

Publications

6.1K

Citations

725

Authors

234

Institutions

Publications per year

2017–2026

14

Authors

725

  1. MG
    Mark G. Papich

    North Carolina State University, United States

    3 publications · 120 citations

    3

    h-index

  2. GL
    Gerald L. Wannarka

    Meridian Medical Systems (United States), United States

    3 publications · 80 citations

    3

    h-index

  3. SJ
    Stanley J. Sarnoff

    Harvard University, United States

    2 publications · 50 citations

    2

    h-index

  4. QM
    Quintin McKellar

    University of Glasgow, United Kingdom

    2 publications · 108 citations

    2

    h-index

  5. LF
    L. Fiume

    University of Bologna, Italy

    2 publications · 63 citations

    2

    h-index

1–5 of 725

Venues

  1. 15

    h-index

  2. PubMed

    Repository · 14 publications · 379 citations

    11

    h-index

  3. Antimicrobial Agents and Chemotherapy

    AAC · 7 publications · 376 citations

    7

    h-index

  4. Biopharmaceutics & Drug Disposition

    6 publications · 197 citations

    6

    h-index

  5. Acta Pharmacologica et Toxicologica

    4 publications · 166 citations

    4

    h-index

1–5